Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006;69(11):1945-53.
DOI: 10.1038/sj.ki.5000414
Peng AW, Dardari ZA, Blumenthal RS, Dzaye O, Obisesan OH, Iftekhar Uddin SM, et al. Very High Coronary Artery Calcium (≥ 1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA. Circulation. 2021;143(16):1571-83.
DOI: 10.1161/CIRCULATIONAHA.120.050545
Chen J, Budoff MJ, Reilly MP, Yang W, Rosas SE, Rahman M, et al. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. JAMA Cardiol 2017;2(6):635-43.
DOI: 10.1001/jamacardio.2017.0363
Rodríguez-García M, Gómez-Alonso C, Naves-Díaz M, Díaz-López JB, Díaz-Corte C, Cannata-Andía JB. Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol, Dial, Transplant 2009;24(1):239-46.
DOI: 10.1093/ndt/gfn466
Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT. Targeting Vascular Calcification in Chronic Kidney Disease. JACC Basic Transl Sci 2020;5(4):398-412.
DOI: 10.1016/j.jacbts.2020.02.002
Dilsizian V, Gewirtz H, Marwick TH, Kwong RY, Raggi P, Al-Mallah MH, et al. Cardiac Imaging for Coronary Heart Disease Risk Stratification in Chronic Kidney Disease. JACC Cardiovasc Imaging 2021;14(3):669-82.
DOI: 10.1016/j.jcmg.2020.05.035
Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? CJASN 2008;3(2):505-21.
DOI: 10.2215/CJN.03670807
Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. JASN 2009;20(2):381-7.
DOI: 10.1681/ASN.2008040349
Román-García P, Carrillo-López N, Cannata-Andía JB. Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia. J Renal Care 2009;35(Suppl.1):34-8.
DOI: 10.1111/j.1755-6686.2009.00050.x
Cannata-Andia JB, Román-García P, Hruska K. The connections between vascular calcification and bone health. Nephrol Dial Transplant 2011;26(11):3429-36.
DOI: 10.1093/ndt/gfr591
Shanahan CM. Vascular calcification-a matter of damage limitation? Nephrol Dial Transplant 2006;21(5):1166-9.
DOI: 10.1093/ndt/gfl089
Zhu D, Mackenzie NC, Farquharson C, Macrae VE. Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne) 2012;3:95.
DOI: 10.3389/fendo.2012.00095
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976;72:248-54.
DOI: 10.1016/0003-2697(76)90527-3
Qian Y, Li L, Sun Z, Liu J, Yuan W, Wang Z. A multi-omics view of the complex mechanism of vascular calcification. Biomed Pharmacother 2021;135:111192.
DOI: 10.1016/j.biopha.2020.111192
Carrillo López N, Tuñón LePoultel D, Quirós Caso C, Rodríguez I, Cannata Andía J, Naves Díaz M. Efecto de dosis suprafisiológicas de calcitriol sobre la expresión proteica de células de músculo liso vascular Rev Osteoporos Metab Miner 2017;9:130-8.
DOI: 10.4321/S1889-836X2017000400005
Fratzl-Zelman N, Bächinger HP, Vranka JA, Roschger P, Klaushofer K, Rauch F. Bone matrix hypermineralization in prolyl-3 hydroxylase 1 deficient mice. Bone 2016;85:15-22.
DOI: 10.1016/j.bone.2016.01.018
Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak J, Jr., Pomerantzeff PM, et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol 2008;28(3):463-70.
DOI: 10.1161/ATVBAHA.107.156745
Pescatore LA, Nolasco P, Farias-Silva E, Jensen L, Fernandes CG, Almeida YE, et al. Abstract 641: Protein Disulfide Isomerase-A1 Overexpression Enhances Vascular Calcification in Mice 2017;37(Suppl.1):A641-A.
DOI: 10.1161/atvb.37.suppl_1.641
Dupont A, Corseaux D, Dekeyzer O, Drobecq H, Guihot AL, Susen S, et al. The proteome and secretome of human arterial smooth muscle cells. Proteomics 2005;5(2):585-96.
DOI: 10.1002/pmic.200400965
Ding X, Qiu Y, Wu G, Li S, Cai M, Liang Y, et al. l-thyroxine attenuates extracellular Hsp90α-induced vascular endothelial calcification in diabetes mellitus, as revealed by parallel metabolic profiles. Atherosclerosis 2024;392:117527.
DOI: 10.1016/j.atherosclerosis.2024.117527
Shen Q, Chen Q, Liu Y, Xue X, Shen X, He Q, et al. Aspirin relieves the calcification of aortic smooth muscle cells by enhancing the heat shock response. Pharmaceutical Biol 2022;60(1):17-24.
DOI: 10.1080/13880209.2021.2007268
Boccardi C, Cecchettini A, Caselli A, Camici G, Evangelista M, Mercatanti A, et al. A proteomic approach to the investigation of early events involved in the activation of vascular smooth muscle cells. Cell Tissue Res 2007;329(1):119-28.
DOI: 10.1007/s00441-007-0407-5
Wanderling S, Simen BB, Ostrovsky O, Ahmed NT, Vogen SM, Gidalevitz T, et al. GRP94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion. Mol Biol Cell. 2007;18(10):3764-75.
DOI: 10.1091/mbc.e07-03-0275
Zhou X, Cui Y, Luan J, Zhou X, Zhang G, Zhang X, et al. Label-free quantification proteomics reveals novel calcium binding proteins in matrix vesicles isolated from mineralizing Saos-2 cells. Bioscience Trends 2013;7(3):144-51.
Chang Z, Yan G, Yan H, Zheng J, Liu Z. Reticulocalbin 2 enhances osteogenic differentiation of human vascular smooth muscle cells in diabetic conditions. Life Sci 2019;233:116746.
DOI: 10.1016/j.lfs.2019.116746
Xiao Z, Blonder J, Zhou M, Veenstra TD. Proteomic analysis of extracellular matrix and vesicles. J Proteomics 2009;72(1):34-45.
DOI: 10.1016/j.jprot.2008.11.011
Kapustin AN, Davies JD, Reynolds JL, McNair R, Jones GT, Sidibe A, et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res 2011;109(1):e1-12.
DOI: 10.1161/CIRCRESAHA.110.238808
Lin P, Le-Niculescu H, Hofmeister R, McCaffery JM, Jin M, Hennemann H, et al. The mammalian calcium-binding protein, nucleobindin (CALNUC), is a Golgi resident protein. J Cell Biol 1998;141(7):1515-27.
DOI: 10.1083/jcb.141.7.1515
Quirós-González I, Román-García P, Alonso-Montes C, Barrio-Vázquez S, Carrillo-López N, Naves-Díaz M, et al. Lamin A is involved in the development of vascular calcification induced by chronic kidney failure and phosphorus load. Bone 2016;84:160-8.
DOI: 10.1016/j.bone.2016.01.005
Carrillo-López N, Panizo S, Martín-Carro B, Mayo Barrallo JC, Román-García P, García-Castro R, et al. Redox Metabolism and Vascular Calcification in Chronic Kidney Disease. Biomolecules 2023;13(9).
DOI: 10.3390/biom13091419
De la Cuesta F, Zubiri I, Maroto AS, Posada M, Padial LR, Vivanco F, et al. Deregulation of smooth muscle cell cytoskeleton within the human atherosclerotic coronary media layer. J Proteomics 2013;82:155-65.
DOI: 10.1016/j.jprot.2013.01.032
Gil-Dones F, Martín-Rojas T, López-Almodóvar LF, Juárez-Tosina R, De la Cuesta F, Álvarez-Llamas G, et al. Obtención de un protocolo óptimo para el análisis proteómico de válvulas aórticas humanas sanas y estenóticas. Revista Española de Cardiología 2010;63(1):46-53.
DOI: 10.1016/S0300-8932(10)70008-7
Bagnato C, Thumar J, Mayya V, Hwang SI, Zebroski H, Claffey KP, et al. Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 2007;6(6):1088-102.
DOI: 10.1074/mcp.M600259-MCP200